Type 16 vaccine 'most exciting news in HPV infections in recent years'

Non-genital warts continue to be almost as common as acne in the dermatology practice, according to Dr. Beutner.

Related Videos
Related Content

Managing Office Politics and Clinical Negotiations With Neal Bhatia, MD

March 18th 2023

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

August 5th 2021

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

March 7th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD

February 18th 2023

Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential

February 8th 2023

Managing Office Politics and Clinical Negotiations With Neal Bhatia, MD

March 18th 2023

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

August 5th 2021

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

March 7th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD

February 18th 2023

Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential

February 8th 2023

Managing Office Politics and Clinical Negotiations With Neal Bhatia, MD

March 18th 2023

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

August 5th 2021

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

March 7th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD

February 18th 2023

Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential

February 8th 2023
© 2023 MJH Life Sciences

All rights reserved.